These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9765971)

  • 21. Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells.
    Hoivik D; Wilson C; Wang W; Willett K; Barhoumi R; Burghardt R; Safe S
    Arch Biochem Biophys; 1997 Dec; 348(1):174-82. PubMed ID: 9390189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens.
    Drewes T; Clairmont A; Klein-Hitpass L; Ryffel GU
    Eur J Biochem; 1994 Oct; 225(1):441-8. PubMed ID: 7925467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
    Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
    Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation.
    Shao ZM; Sheikh MS; Rishi AK; Dawson MI; Li XS; Wilber JF; Feng P; Fontana JA
    Exp Cell Res; 1995 May; 218(1):1-8. PubMed ID: 7737350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG
    Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An N-terminal deletion mutant of estrogen receptor exhibits increased synergism with upstream activators and enhanced binding to the estrogen response element.
    Xing H; Mattick S; Lew D; Shapiro DJ
    Biochemistry; 1995 Mar; 34(12):3956-63. PubMed ID: 7696260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of estrogen receptor-alpha by the heavy metal cadmium.
    Stoica A; Katzenellenbogen BS; Martin MB
    Mol Endocrinol; 2000 Apr; 14(4):545-53. PubMed ID: 10770491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
    Ignar-Trowbridge DM; Teng CT; Ross KA; Parker MG; Korach KS; McLachlan JA
    Mol Endocrinol; 1993 Aug; 7(8):992-8. PubMed ID: 8232319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
    Galien R; Garcia T
    Nucleic Acids Res; 1997 Jun; 25(12):2424-9. PubMed ID: 9171095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.
    Crowe DL; Brown TN
    Neoplasia; 1999 Oct; 1(4):368-72. PubMed ID: 10935492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.
    McInerney EM; Tsai MJ; O'Malley BW; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10069-73. PubMed ID: 8816752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis.
    Virbasius JV; Scarpulla RC
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1309-13. PubMed ID: 8108407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
    Hurd C; Dinda S; Khattree N; Moudgil VK
    Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression.
    Miller DL; el-Ashry D; Cheville AL; Liu Y; McLeskey SW; Kern FG
    Cell Growth Differ; 1994 Dec; 5(12):1263-74. PubMed ID: 7696175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells.
    Speir E; Yu ZX; Takeda K; Ferrans VJ; Cannon RO
    Circ Res; 2000 Nov; 87(11):1006-11. PubMed ID: 11090545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell.
    Abbondanza C; Rossi V; Roscigno A; Gallo L; Belsito A; Piluso G; Medici N; Nigro V; Molinari AM; Moncharmont B; Puca GA
    J Cell Biol; 1998 Jun; 141(6):1301-10. PubMed ID: 9628887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
    Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
    Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression.
    Porter W; Wang F; Wang W; Duan R; Safe S
    Mol Endocrinol; 1996 Nov; 10(11):1371-8. PubMed ID: 8923463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.